▲ +291.63% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Millendo Therapeutics in the last 3 months. The average price target is $3.80, with a high forecast of $6.00 and a low forecast of $2.00. The average price target represents a 291.63% upside from the last price of $0.97.
The current consensus among 6 investment analysts is to hold stock in Millendo Therapeutics. This rating has held steady since August 2020, when it changed from a Buy consensus rating.